Total Payments
$5,553
2024 Payments
$630.15
Companies
53
Transactions
317
Medicare Patients
16,258
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$5,112 (92.1%)
Education$441.01 (7.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,112 | 310 | 92.1% |
| Education | $441.01 | 7 | 7.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $800.08 | 44 | $0 (2023) |
| ABBVIE INC. | $529.95 | 37 | $0 (2024) |
| Janssen Biotech, Inc. | $496.49 | 24 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $391.74 | 26 | $0 (2024) |
| PFIZER INC. | $390.16 | 28 | $0 (2024) |
| 180 Medical, Inc. | $201.06 | 11 | $0 (2024) |
| Medtronic USA, Inc. | $165.89 | 5 | $0 (2019) |
| Myriad Genetic Laboratories, Inc. | $158.96 | 11 | $0 (2024) |
| Coloplast Corp | $153.81 | 9 | $0 (2022) |
| TOLMAR Pharmaceuticals, Inc. | $143.44 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $630.15 | 35 | Janssen Biotech, Inc. ($83.11) |
| 2023 | $676.50 | 41 | ABBVIE INC. ($107.27) |
| 2022 | $780.18 | 39 | Janssen Biotech, Inc. ($143.35) |
| 2021 | $610.62 | 36 | Janssen Biotech, Inc. ($119.36) |
| 2020 | $466.39 | 27 | Astellas Pharma US Inc ($140.51) |
| 2019 | $714.11 | 41 | Medtronic USA, Inc. ($106.35) |
| 2018 | $855.88 | 49 | Astellas Pharma US Inc ($168.10) |
| 2017 | $819.31 | 49 | Astellas Pharma US Inc ($274.55) |
All Payment Transactions
317 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: UROLOGY | ||||||
| 09/27/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Oncology | ||||||
| 08/30/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Oncology | ||||||
| 08/16/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $14.07 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $14.17 | General |
| 08/08/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/01/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Oncology | ||||||
| 07/26/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $16.34 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/21/2024 | Agiliti Surgical, Inc. | Sonablate HIFU (Device), Dornier Thulio | Food and Beverage | Cash or cash equivalent | $26.15 | General |
| Category: Surgical Lasers | ||||||
| 06/06/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/05/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: ONCOLOGY | ||||||
| 05/29/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Oncology | ||||||
| 05/25/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: UROTHELIAL CANCER | ||||||
| 05/15/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $19.88 | General |
| 05/10/2024 | Teleflex LLC | SOLESTA (Device) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 05/02/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $16.75 | General |
| Category: ONCOLOGY | ||||||
| 04/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Oncology | ||||||
| 04/25/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $15.84 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 4,639 | 10,550 | $3.1M | $434,302 |
| 2022 | 31 | 4,251 | 6,190 | $2.6M | $380,626 |
| 2021 | 34 | 3,780 | 6,042 | $1.5M | $366,542 |
| 2020 | 38 | 3,588 | 5,832 | $1.2M | $302,342 |
Total Patients
16,258
Total Services
28,614
Medicare Billing
$1.5M
Procedure Codes
153
All Medicare Procedures & Services
153 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 783 | 1,432 | $1.0M | $141,267 | 13.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 557 | 777 | $389,277 | $52,162 | 13.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 270 | 442 | $168,844 | $29,141 | 17.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 203 | 223 | $160,506 | $24,030 | 15.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 22 | 162 | $115,020 | $21,813 | 19.0% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 36 | 585 | $67,860 | $20,117 | 29.6% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 26 | 31 | $128,774 | $14,652 | 11.4% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 36 | 135 | $31,455 | $9,288 | 29.5% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 403 | 557 | $8,355 | $8,173 | 97.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $57,645 | $7,770 | 13.5% |
| 52649 | Complete laser fragmentation of prostate including control of bleeding using an endoscope | Facility | 2023 | 11 | 11 | $49,247 | $7,581 | 15.4% |
| 51703 | Complicated insertion of bladder tube | Office | 2023 | 26 | 57 | $47,766 | $7,038 | 14.7% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 19 | 2,951 | $162,010 | $6,673 | 4.1% |
| 51710 | Complicated change of bladder tube | Office | 2023 | 13 | 54 | $41,418 | $6,140 | 14.8% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 15 | 18 | $40,014 | $5,964 | 14.9% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 17 | 17 | $36,312 | $5,462 | 15.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 22 | 26 | $34,918 | $5,356 | 15.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 438 | 607 | $9,105 | $5,065 | 55.6% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 36 | 135 | $15,660 | $4,642 | 29.6% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 19 | 61 | $30,561 | $4,495 | 14.7% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 41 | 43 | $60,587 | $4,183 | 6.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 52 | 52 | $32,032 | $4,125 | 12.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 52 | 60 | $80,580 | $3,921 | 4.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 21 | 25 | $63,625 | $3,547 | 5.6% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 20 | 20 | $21,660 | $3,411 | 15.7% |
About Dr. Michael Howard, M.D
Dr. Michael Howard, M.D is a Urology healthcare provider based in Manasquan, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174595508.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Howard, M.D has received a total of $5,553 in payments from pharmaceutical and medical device companies, with $630.15 received in 2024. These payments were reported across 317 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($5,112).
As a Medicare-enrolled provider, Howard has provided services to 16,258 Medicare beneficiaries, totaling 28,614 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 153 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Manasquan, NJ
- Active Since 02/01/2006
- Last Updated 02/09/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1174595508
Products in Payments
- XTANDI (Drug) $494.50
- PROVENGE (Drug) $409.70
- ERLEADA (Drug) $359.19
- ELIGARD (Drug) $269.41
- INTERSTIM (Device) $266.50
- Myrbetriq (Drug) $247.00
- LUPRON DEPOT (Drug) $209.10
- Androgel (Drug) $200.97
- Xtandi (Drug) $120.97
- KEYTRUDA (Biological) $113.16
- ZYTIGA (Drug) $112.33
- TOVIAZ (Drug) $110.60
- LoFric (Device) $110.37
- Erleada (Drug) $103.38
- ORGOVYX (Drug) $99.99
- Natesto (Drug) $93.73
- PROLARIS (Device) $91.14
- BOTOX (Biological) $89.46
- SPEEDICATH (Device) $78.64
- CAMCEVI (Drug) $74.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.